DK366785A - Fremgangsmaade til behandling af collagen-holdigt vaev - Google Patents

Fremgangsmaade til behandling af collagen-holdigt vaev Download PDF

Info

Publication number
DK366785A
DK366785A DK366785A DK366785A DK366785A DK 366785 A DK366785 A DK 366785A DK 366785 A DK366785 A DK 366785A DK 366785 A DK366785 A DK 366785A DK 366785 A DK366785 A DK 366785A
Authority
DK
Denmark
Prior art keywords
procedure
treating collagen
contained web
web
contained
Prior art date
Application number
DK366785A
Other languages
English (en)
Other versions
DK366785D0 (da
Inventor
Mrinal Kanti Dewanjee
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Publication of DK366785D0 publication Critical patent/DK366785D0/da
Publication of DK366785A publication Critical patent/DK366785A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK366785A 1984-08-14 1985-08-13 Fremgangsmaade til behandling af collagen-holdigt vaev DK366785A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/640,725 US4553974A (en) 1984-08-14 1984-08-14 Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor

Publications (2)

Publication Number Publication Date
DK366785D0 DK366785D0 (da) 1985-08-13
DK366785A true DK366785A (da) 1986-02-15

Family

ID=24569463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK366785A DK366785A (da) 1984-08-14 1985-08-13 Fremgangsmaade til behandling af collagen-holdigt vaev

Country Status (8)

Country Link
US (1) US4553974A (da)
EP (1) EP0174737A3 (da)
JP (1) JPS61137825A (da)
AU (1) AU558688B2 (da)
CA (1) CA1247007A (da)
DK (1) DK366785A (da)
MX (1) MX161342A (da)
ZA (1) ZA856106B (da)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883864A (en) * 1985-09-06 1989-11-28 Minnesota Mining And Manufacturing Company Modified collagen compound and method of preparation
US5108923A (en) * 1986-04-25 1992-04-28 Collaborative Research, Inc. Bioadhesives for cell and tissue adhesion
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
JPH01500730A (ja) * 1986-08-20 1989-03-16 ザ・チャイルドレンズ・メディカル・センター・コーポレーション 生物学的材料移植片
US4786287A (en) * 1986-10-10 1988-11-22 Baxter Travenol Laboratories Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue
JPS63117121A (ja) * 1986-11-05 1988-05-21 Honda Motor Co Ltd 内燃機関の複合吸気系制御方法
US4865602A (en) * 1986-11-06 1989-09-12 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US4838888A (en) * 1987-04-17 1989-06-13 Baxter Travenol Laboratories, Inc. Calcification mitigation of implantable bioprostheses
US5139527A (en) * 1987-12-17 1992-08-18 Immuno Aktiengesellschaft Biologic absorbable implant material for filling and closing soft tissue cavities and method of its preparation
US4976733A (en) * 1988-02-03 1990-12-11 Biomedical Design, Inc. Prevention of prosthesis calcification
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US5746775A (en) * 1988-04-01 1998-05-05 The Board Of Regent6S Of The University Of Michigan Method of making calcification-resistant bioprosthetic tissue
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5002566A (en) * 1989-02-17 1991-03-26 Baxter International Inc. Calcification mitigation of bioprosthetic implants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US6004261A (en) * 1989-04-28 1999-12-21 C. R. Bard, Inc. Formed-in-place endovascular stent and delivery system
AT398276B (de) * 1989-05-31 1994-11-25 Sorin Biomedica Spa Verfahren zur präparierung von biologischem implantationsmaterial
US5609626A (en) * 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
DE4028088A1 (de) * 1990-09-05 1992-04-16 Berg Ernes Elme Dipl Ing Resorbierbare kollagenimplantate
CA2101557A1 (en) * 1991-02-14 1992-08-15 Roger Tu Pliable biological graft materials and their methods of manufacture
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5513662A (en) * 1991-12-31 1996-05-07 Osteotech, Inc. Preparation of bone for transplantation
US5476516A (en) * 1992-03-13 1995-12-19 Albert Einstein College Of Medicine Of Yeshiva University Anticalcification treatment for aldehyde-tanned biological tissue
US5509932A (en) * 1993-04-08 1996-04-23 Keogh; James R. Fixed tissue medical devices comprising albumin-binding dyes
US6203755B1 (en) * 1994-03-04 2001-03-20 St. Jude Medical, Inc. Electron beam sterilization of biological tissues
AU1931495A (en) * 1994-03-14 1995-10-03 Cryolife, Inc. Treated tissue for implantation and preparation methods
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
AU2399495A (en) * 1994-04-29 1995-11-29 W.L. Gore & Associates, Inc. Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix
JPH09512463A (ja) * 1994-04-29 1997-12-16 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 天然内皮下基質を利用した改善された血液接触表面並びにその製造及び利用方法
US5797871A (en) * 1994-08-19 1998-08-25 Lifenet Research Foundation Ultrasonic cleaning of allograft bone
US5556379A (en) * 1994-08-19 1996-09-17 Lifenet Research Foundation Process for cleaning large bone grafts and bone grafts produced thereby
US5977034A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Composition for cleaning bones
US5976104A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Recirculation method for cleaning essentially intact bone grafts using pressure mediated flow of solutions and bone grafts produced thereby
AUPN174495A0 (en) 1995-03-15 1995-04-06 Ketharanathan, Vettivetpillai Surgical prostheses
AU5564996A (en) * 1995-04-19 1996-11-07 St. Jude Medical Inc. Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
ES2420106T3 (es) 1995-12-18 2013-08-22 Angiodevice International Gmbh Composiciones de polímeros reticulados y métodos para su uso
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US7883693B2 (en) 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
US5782931A (en) * 1996-07-30 1998-07-21 Baxter International Inc. Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
US6121041A (en) * 1996-07-31 2000-09-19 St. Jude Medical, Inc. Use of microorganisms for decellularizing bioprosthetic tissue
US5782914A (en) * 1996-11-29 1998-07-21 Bio-Vascular, Inc. Method for preparing heterogeneous tissue grafts
US5862806A (en) * 1997-10-30 1999-01-26 Mitroflow International, Inc. Borohydride reduction of biological tissues
US20080077251A1 (en) * 1999-06-07 2008-03-27 Chen Silvia S Cleaning and devitalization of cartilage
US8563232B2 (en) 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
CA2345799C (en) * 1998-09-30 2010-01-05 Medtronic, Inc. Process for reducing mineralization of tissue used in transplantation
US6214055B1 (en) * 1998-10-30 2001-04-10 Mures Cardiovascular Research, Inc. Method and kit for rapid preparation of autologous tissue medical devices
US20020081732A1 (en) * 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
US20020042128A1 (en) * 2000-09-01 2002-04-11 Bowlin Gary L. Electroprocessed fibrin-based matrices and tissues
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
US6471723B1 (en) * 2000-01-10 2002-10-29 St. Jude Medical, Inc. Biocompatible prosthetic tissue
US20070055367A1 (en) * 2000-03-15 2007-03-08 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
US8088060B2 (en) * 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
CA2400319C (en) 2000-03-15 2008-09-16 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US8460367B2 (en) * 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US7510572B2 (en) * 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
AUPR217300A0 (en) * 2000-12-20 2001-01-25 Ketharanathan, Vettivetpillai Method of creating biological and biosynthetic material for implantation
US20020177223A1 (en) * 2001-03-12 2002-11-28 Ogle Mathew F. Methods and compositions for crosslinking tissue
US7078163B2 (en) * 2001-03-30 2006-07-18 Medtronic, Inc. Process for reducing mineralization of tissue used in transplantation
US7182725B2 (en) * 2001-09-24 2007-02-27 Best Vascular, Inc. Methods and apparatus employing ionizing radiation for treatment of cardiac arrhythmia
US7008591B2 (en) * 2001-10-17 2006-03-07 Edwards Lifesciences Corporation Supercritical fluid extraction process for tissue preparation
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US8308797B2 (en) * 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
WO2003082203A2 (en) * 2002-03-27 2003-10-09 University Of Utah Research Foundation Elastin prevents occlusion of body vessels by vascular smooth muscle cells
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
ES2561463T3 (es) * 2003-08-21 2016-02-26 Addbio Ab Dispositivo de implante recubierto con bisfosfonato y método para el mismo
US7955788B2 (en) * 2003-10-30 2011-06-07 Medtronic, Inc. Bioprosthetic tissue preparation with synthetic hydrogels
WO2005086831A2 (en) * 2004-03-10 2005-09-22 Orbus Medical Technologies, Inc. Endothelial ligand binding coated medical device
US7648676B2 (en) * 2004-04-20 2010-01-19 Rti Biologics, Inc. Process and apparatus for treating implants comprising soft tissue
US20060228252A1 (en) * 2004-04-20 2006-10-12 Mills C R Process and apparatus for treating implants comprising soft tissue
CN104174071A (zh) 2004-04-28 2014-12-03 安希奥设备国际有限责任公司 用于形成交联生物材料的组合物和系统及关联的制备方法与用途
EP2946666B1 (en) * 2004-04-30 2017-11-15 OrbusNeich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
WO2005118014A2 (en) * 2004-06-01 2005-12-15 Medtronic, Inc. Decellurisation processes for making bioprotheses
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
EP1796602A4 (en) 2004-09-17 2016-10-19 Angiotech Pharm Inc MULTIFUNCTIONAL COMPOUNDS FOR PRODUCING NETWORKED BIOMATERIALS AND MANUFACTURING AND USE METHOD THEREFOR
DE102004047247B3 (de) * 2004-09-22 2006-03-16 Auto Tissue Gmbh Sterilisationsverfahren zur Herstellung von implantierbarem oder transplantierbarem biologischem Material
US7989157B2 (en) * 2005-01-11 2011-08-02 Medtronic, Inc. Solution for storing bioprosthetic tissue used in a biological prosthesis
US8445278B2 (en) * 2005-03-01 2013-05-21 Medtronic, Inc. Process for producing decellularized biological tissues
US8764820B2 (en) 2005-11-16 2014-07-01 Edwards Lifesciences Corporation Transapical heart valve delivery system and method
CN103933612B (zh) 2006-10-27 2016-06-22 爱德华兹生命科学公司 用于外科植入的生物组织
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
FR2917625B1 (fr) * 2007-06-20 2009-09-18 Perouse Soc Par Actions Simpli Traitement de dispositifs medicaux implantables resistants a la calcification
US9744043B2 (en) 2007-07-16 2017-08-29 Lifenet Health Crafting of cartilage
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
US8211165B1 (en) 2008-01-08 2012-07-03 Cook Medical Technologies Llc Implantable device for placement in a vessel having a variable size
US20100040593A1 (en) * 2008-08-15 2010-02-18 Orthopeutics, Lp Formulations for nonsurgical exogenous crosslink therapy
US8439970B2 (en) 2009-07-14 2013-05-14 Edwards Lifesciences Corporation Transapical delivery system for heart valves
CA2794121C (en) 2010-03-23 2016-10-11 Edwards Lifesciences Corporation Methods of conditioning sheet bioprosthetic tissue
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
WO2011160085A2 (en) 2010-06-17 2011-12-22 Edwards Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
WO2012027515A2 (en) * 2010-08-24 2012-03-01 Southern Lights Ventures 2002 Limited Biomaterials with enhanced properties and devices made therefrom
AU2015202239B2 (en) * 2010-08-24 2016-11-17 Collagen Solutions Nz Limited Biomaterials with enhanced properties and devices made therefrom
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
CA3027755C (en) 2010-12-14 2021-05-11 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US9381082B2 (en) 2011-04-22 2016-07-05 Edwards Lifesciences Corporation Devices, systems and methods for accurate positioning of a prosthetic valve
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
US10149757B2 (en) 2013-03-15 2018-12-11 Edwards Lifesciences Corporation System and method for transaortic delivery of a prosthetic heart valve
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
EP3134033B1 (en) 2014-05-29 2018-04-04 Edwards Lifesciences CardiAQ LLC Prosthesis and delivery device
WO2018222434A1 (en) 2017-05-31 2018-12-06 Edwards Lifesciences Corporation Collagen fibers and articles formed therefrom
SG11202003938PA (en) 2018-01-23 2020-08-28 Edwards Lifesciences Corp Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
EP3852683B1 (en) 2018-11-01 2024-05-29 Edwards Lifesciences Corporation Transcatheter pulmonic regenerative valve

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1317584A (fr) * 1961-03-15 1963-02-08 Olin Mathieson Méthode de traitement des tissus osseux et autres tissus
AT261800B (de) * 1966-08-22 1968-05-10 Braun Internat Gmbh B Verfahren zur Herstellung von röhrenförmigen, glatten bzw. mit einem Gewinde versehenen Gewebe-Blutgefäß-Prothesen
US3988782A (en) * 1973-07-06 1976-11-02 Dardik Irving I Non-antigenic, non-thrombogenic infection-resistant grafts from umbilical cord vessels and process for preparing and using same
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate
US3966401A (en) * 1974-07-01 1976-06-29 Hancock Laboratories Incorporated Preparing natural tissue for implantation so as to provide improved flexibility
IL47062A (en) * 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
JPS5230097A (en) * 1975-09-02 1977-03-07 Kaneyasu Miyata Method of mounting different substitute blood vessel
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US4323358A (en) * 1981-04-30 1982-04-06 Vascor, Inc. Method for inhibiting mineralization of natural tissue during implantation
US4402697A (en) * 1982-08-25 1983-09-06 Extracorporeal Medical Specialties, Inc. Method for inhibiting mineralization of natural tissue during implantation
DE3379568D1 (en) * 1982-11-12 1989-05-18 Baxter Int Surfactant treatment of implantable biological tissue to inhibit calcification

Also Published As

Publication number Publication date
MX161342A (es) 1990-09-10
CA1247007A (en) 1988-12-20
AU4613085A (en) 1986-03-27
DK366785D0 (da) 1985-08-13
US4553974A (en) 1985-11-19
EP0174737A2 (en) 1986-03-19
EP0174737A3 (en) 1987-03-11
ZA856106B (en) 1987-03-25
JPS61137825A (ja) 1986-06-25
AU558688B2 (en) 1987-02-05

Similar Documents

Publication Publication Date Title
DK366785A (da) Fremgangsmaade til behandling af collagen-holdigt vaev
DK308085D0 (da) Fremgangsmaade til ekstrudering af silicaholdige materialer
DK162647C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK162580C (da) Fremgangsmaade til fremstilling af mikrokapsler
DK27485A (da) Fremgangsmaade til behandling af kvaeg
DK24386D0 (da) Fremgangsmaade til behandling af olieholdigt froemateriale
DK474585A (da) Fremgangsmaade til mikroindkapsling
ES544895A0 (es) Procedimiento para tratar papelote
DK160829C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK156085D0 (da) Fremgangsmaade til fremstilling af acetoxyazetidinoner
DK294584D0 (da) Fremgangsmaade til fremstilling af formparter
DK304185D0 (da) Fremgangsmaade til fremstilling af furanon
DK448489D0 (da) Fremgangsmaade til behandling af tekstiler
DK138485A (da) Fremgangsmaade til rensning af enzymholdig oploesning
DK409485A (da) Fremgangsmaade til justering af betons egenskaber
DK509587D0 (da) Fremgangsmaade til inhibering af genekspression
TR22771A (tr) Gelistirilmis tuetuen yayma usulue
DK190385D0 (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK164649C (da) Fremgangsmaade til fremstilling af jernbanehjul
DK357685A (da) Fremgangsmaade til makrolid alkylering
DK420688A (da) Fremgangsmaade til behandling af phosphorholdigt materiale
DK420788A (da) Fremgangsmaade til behandling af phosphorholdigt materiale
DK556385A (da) Fremgangsmaade til regulering af maltbygs spiring
DK521885A (da) Fremgangsmaade til fremstilling af benzopyranotriazoler
DK40284A (da) Fremgangsmaade til fremstilling af n-phosphonmethylglycin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment